ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Zakayo Ernesti, Emanuel Lugina, Chacha J Mwita, Felister Tupa, Herriethsiah S Noah, John R Ngowi, Charles Wood, Julius Mwaiselage, Salum J Lidenge
Edwin Saji, Jason Jacob, Udaya Kumar Damodaran, Sabah Kulsum, Sharanya Tripathi, Akshat Saxena, Panah Parab, Utkarsh Dayal, Priyal Dilip Mehta, Aju Mathew
Sandro Casavilca-Zambrano, Juan Contreras-Mancilla, Camille Laurent, Jaqueline Montoya, Rosdali Diaz-Coronado, Jorge Honles, Ruddy Liendo-Picoaga, Jenny Bonifacio-Mundaca, Jhoysi Casas-Goñas, Juan Pablo Cerapio, Carlos Barrionuevo, Tatiana Vidaurre, Stéphane Bertani
Chase Peng Yun Ng, Asmita Raja, Alicia Hunter, Sai Kalpitha Eragamreddy, Grace Tan, Shahin Sayed, Looi Lai-Meng, Leke Folaranmi, Beatriz Hornburg, Meritxell Mallafre-Larrosa, Julie Torode, Ajay Aggarwal, Kenneth Fleming, Richard Sullivan
Elizabeth Hatzaw, Jane Ralte, Vignesh Krishnasamy, Lalengkimi Ralte, Rajendra Bose Muthukumaran, Kasi Marimuthu, Nachimuthu Senthil Kumar
Ryan R. Lion, Glenn Mbah, Nathalie De Sousa Santos, Anne Gagnepain-Lacheteau, Karim Assani, Aissata Barry, Viviane Bissyande, Chantal Bouda, Aleine Budiongo, Isaac Bahati Chuma, Line Couitchéré, Fatou Binetou Diagne Akondé, Mame Ndella Diouf, Aimée Kissou, Robert Lukamba Mbuli, Boubacar Togo, Kan Paulin Yao, Yao Atteby Jean Jacques, Lea Zaho, Ekhtelbenina Zein, Isatou Bah Madison, Laila Hessissen